← SynDRA
BUTEIN
SynDRA canonical compound SYN0004535 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | ACE | CXCL8 | IL6 | SIRT1 | SRD5A1 | SRD5A2 | TNF |
| Mechanism of action | EGFR inhibitor | SRC inhibitor |
All known targets
- ACE
- CXCL8
- IL6
- Malaria fabI
- SIRT1
- SLC33A1
- SRD5A1
- SRD5A2
- TNF
Mechanisms of action (all sources)
- EGFR INHIBITOR
- SRC inhibitor
- SLC33A1 INHIBITOR
- Inhibitor
Cross-references
Synonyms
- 2',3,4,4'-Tetrahydroxychalcone
- 3,4,2',4'-Tetrahydroxychalcone
- 2',4',3,4-Tetrahydroxychalcone
- UNII-4WVS5M0LGF
- EINECS 207-659-5
- 4WVS5M0LGF
- (E)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one
- CHEMBL128000
- CHEBI:3237
- (2E)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one
- 1-(2,4-Dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-2-propen-1-one
- ,3,4-Tetrahydroxychalcone
- Chalcone, 2',3,4,4'-tetrahydroxy- (7CI,8CI)
- Acrylophenone, 2',4'-dihydroxy-3-(3,4-dihy
- NSC-652892
- RefChem:30964
- DTXCID801509815
- 2',3,4,4'-Tetrahydroxy-chalcone
- AC1NQY7L
- MFCD00017300
- Chalcone, 2',3,4,4'-tetrahydroxy-
- Butein, solid
- AYMYWHCQALZEGT-ORCRQEGFSA-N
- Butein (Standard)
- butein [M+H]+
- Butein, analytical standard
- SCHEMBL139243
- orb1300778
- SCHEMBL29724857
- 2,3,4,4-tetrahydroxy Chalcone
- CHEBI:92312
- Acrylophenone, 2',4'-dihydroxy-3-(3,4-dihydroxyphenyl)-
- 3,4,2'',4''-tetrahydroxychalone
- BDBM50042949
- HSCI1_000162
- HY-16558R
- LMPK12120111
- NSC652892
Look up BUTEIN in the interactive SynDRA portal →